<DOC>
	<DOCNO>NCT00371371</DOCNO>
	<brief_summary>The purpose study determine whether intra-arterial injection autologous stem cell effective treatment chronic limb ischemia ( CLI ) , characterize stem cell dysfunction patient CLI , relate stem cell function clinical outcome .</brief_summary>
	<brief_title>Intra-arterial Stem Cell Therapy Patients With Chronic Limb Ischemia ( CLI )</brief_title>
	<detailed_description>Despite advance surgical radiological vascular technique , significant number patient chronic critical limb ischaemia ( CLI ) eligible revascularization procedure , often leave amputation option . Consequently , explore new strategy revascularization ischemic limb major importance . Preclinical study pioneer clinical trial suggest administration bone marrow ( BM ) mononuclear cell ( MNC ) ischemic limbs enhances neovascularization , improve tissue perfusion prevents amputation . However , definite proof available clinical study thus far small lack double-blinded control . JUVENTAS randomize , double-blinded placebo-controlled trial 109 - 160 patient CLI investigate potential clinical effect repeat intra-arterial infusion BM-MNC patient ( exact number patient include specify advance plan group sequential interim analysis ) . In addition , study functional characteristic BM-MNC obtain CLI patient relate BM-MNC dysfunction clinical outcome .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Gangrene</mesh_term>
	<criteria>Age &gt; 18 year Severe infrapopliteal peripheral arterial occlusive disease [ PAOD ] ( Fontaine class IIb , III IV ) Invalidating intermittent claudication , persistent , recur rest pain require analgesia and/or nonhealing ulcer present &gt; 4 week without evidence improvement response conventional therapy Ankle brachial index &lt; 0.6 `` unreliable '' Not eligible surgical radiological revascularization Written inform consent History neoplasm malignancy past 10 year Serious know concomitant disease life expectancy le one year Anticipated inability obtain 100 ml bone marrow aspirate Known infection human immunodeficiency virus ( HIV ) , hepatitis B hepatitis C virus Followup impossible</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>clinical trial</keyword>
	<keyword>chronic critical limb ischemia</keyword>
	<keyword>leg pain</keyword>
	<keyword>cell therapy</keyword>
	<keyword>bone marrow</keyword>
	<keyword>mononuclear</keyword>
	<keyword>progenitor cell</keyword>
	<keyword>stem cell</keyword>
	<keyword>critical limb ischemia</keyword>
	<keyword>nonhealing leg ulcer</keyword>
</DOC>